Even though situated at the outskirts of the EU, Poland undoubtedly serves as one of the main pathways into the Union’s affluent west. The importance of its infrastructure is reflected in its prioritized investment position. Looking at investments made by the European Investment Bank alone, one could see that out of the EUR 79.8 billion invested in the country since 1990, about 47% went to infrastructure.

2021 turned out to be a surprise and many 2020 predictions concerning the legal market have not come true (luckily!). Despite predictions, legal advisors continue to be extremely busy. This is especially the case in M&A, real estate, and restructuring.

White & Case has completed a new round of firm-wide promotions, appointing 28 Local Partners and 40 Counsels. Among these were new Local Partners Jakub Gubanski, Aleksandra Oziemska, Bartosz Smardzewski, and Pawel Zagorski in Warsaw, Gokce Uluc in Istanbul, and Marianna Galusova in Prague.

On October 25, 2021, CEE Legal Matters reported that Balicki Czekanski Gryglewski Lewczuk had advised Symfonia on its acquisition of Cloud Planet and Skanuj.to. CEE In-House Matters spoke with Wioletta Kaloska, General Counsel at Symfonia, to learn more about the matter.

Maciej Kalinowski has Joined Spectris Energy as its Head of M&A Legal in Poland.

Former Pfeifer & Langen Poland Head of Legal Sylwia Stepniewska-Idzior has joined SMM Legal as a Partner and will head the firm’s German Desk.

Greenberg Traurig’s Warsaw office has established an Environmental Protection Practice led by Counsel Barbara Pancer.

Linklaters Managing Associate Marta Domino has been appointed Head of the firm’s Banking and Finance practice in Warsaw.

On 18 October 2021, the Council of Ministers has published the draft Act on protection of persons reporting breaches of law. The Act is intended to implement Directive 2019/1937 of the European Parliament and of the Council of 23 October 2019 on the protection of persons who report breaches of Union law ("Directive 2019/1937") into the Polish legal system. The Act establishes rules and procedures for the protection of whistleblowers, i.e., persons who report information obtained in a work-related context about breaches of the European Union law.

Franchising may be an attractive proposition for many companies wishing to expand internationally. Take a look at this overview to discover the applicable franchise law in Poland, covering the essentials for franchisors, the relevant areas of law, selected aspects such as fees, and dispute resolution and applicable law.

A taxpayer cannot resort to the principle of in dubio pro tributario to select an interpretation of a provision of law that is more favourable when a different interpretation is more favourable for the vast majority of taxpayers.

 In “The Corner Office” we ask Managing Partners at law firms across Central and Eastern Europe about their backgrounds, strategies, and responsibilities. With summer having just passed, the question this time: What is your one favorite yearly activity to disconnect?

After a year of unprecedented health and economic challenges, the global economy is trying to recover, and the energy transition needs to be at the heart of this. As a lifeline out of the COVID-19 pandemic, the European Union has proposed the Green Deal, which focuses on achieving zero net emissions by 2050. Can oil and gas companies also lead the transition to a net-zero future in more traditional and heavily carbonized economies, such as Poland?

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the last part of which discusses other consequences of the pandemic not yet mentioned as well as sector barriers and suggested state actions.

The current political atmosphere in Poland is rather turbulent, according to Noerr Partner Radoslaw Biedecki, as the government is losing support and the opposition remains divided.

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the third of which focuses on patients’ rights, the product market and an evaluation of the state’s actions during the pandemic.

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the second of which concentrates on the impact of the pandemic on reimbursement and on the organisation of the healthcare system.

The DLA Piper report “The COVID-19 pandemic and the pharmaceutical and medical sector in Poland” is based on the feedback from a survey conducted among DLA Piper’s clients and business contacts from the pharmaceutical and medical sector, including producers of medicines, food supplements and medical devices, as well as healthcare service providers. It is the first report that brings together the views of key players in the pharmaceutical and medical industries, describing how they see the current state of affairs on the Polish market and possible future trends, along with their recommendations as to what actions they would like to see taken in the sector. The key findings are summarised in our four briefings, the first of which focuses on the overall impact of the pandemic as well as relations with healthcare professionals and clinical trials.